The global pediatric medicines market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Pediatric medicines is a branch of medicines that deals with the development, care for the management of diseases associated with infants, children, and adolescents. The major factor driving the growth of the market include the rising birth rate across the globe.
Moreover, the market is also growing owing to new drug approvals. For instance, in June 2021, Novartis announced the approval of Cosentyx (secukinumab) from the US Food and Drug Administration (FDA). It is used for the treatment of moderate to severe plaque psoriasis in pediatric patients six years and older who are candidates for systemic therapy or phototherapy. Additionally, in September 2021, Amgen announced the approval of Repatha (evolocumab) from the US Food and Drug Administration (FDA). It is used as an adjunct to diet and other low-density lipoprotein cholesterol (LDL-C)-lowering therapies to treat pediatric patients aged 10 years and older with heterozygous familial hypercholesterolemia (HeFH) to reduce LDL-C.
To Request a Sample of our Report on Pediatric Medicines Market: https://www.omrglobal.com/request-sample/pediatric-medicines-market
Some major players in the market include Gilead Sciences Inc., Novartis International AG, and Johnson & Johnson Services, Inc., among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in October 2021, Enzyvant Therapeutics, Inc. announced that it has received approval for Rethymic from the Food and Drug Administration (FDA) in the US. It is used to treat pediatric patients with congenital athymia, a rare immune disorder.
Market Coverage
- The market number available for – 2020-2027
- Base year- 2020
- Forecast period- 2021-2027
Segment Covered-
- By Type
- By Route of Administration
Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
Competitive Landscape– Gilead Sciences Inc., Novartis International AG, and Johnson & Johnson Services, Inc., among others.
(Get 15% Discount on Buying this Report)
A full Report of Pediatric Medicines Market is Available @ https://www.omrglobal.com/industry-reports/pediatric-medicines-market
Global Pediatric Medicines Market Report by Segment
By Type
- Respiratory Disorder Drugs
- Autoimmune Disorder Drugs
- Gastrointestinal Drugs
- Cardiovascular Drugs
- Others
By Route of Administration
- Oral
- Topical
- Parenteral
- Others
Global Pediatric Medicines Market Report by Region
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of the World
- Latin America
- Middle East & Africa
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
